"Complications of surgery or percutaneous drainage include :"
"As a result of the widespread availability of antibiotics, the incidence of lung abscesses has been dramatically reduced. Mortality has similarly been reduced. The elderly, immunocompromised, malnourished, debilitated, and, of course, those who do not have access to antibiotics are particularly susceptible and have the worst prognosis 6. The rate is on the rise, though, particularly due to an increased number of immunocompromised patients (secondary to HIV/AIDS and iatrogenic immunosuppression) 7."
"Lung abscesses are divided, according to their duration, into acute (6 weeks) 7. The presentation is usually non-specific and generally similar to a non-cavitating chest infection. Symptoms include fever, cough and shortness of breath. Peripheral abscesses may also cause pleuritic chest pain 7."
"Lung abscesses are divided, according to their duration, into acute (6 weeks) 7. The presentation is usually non-specific and generally similar to a non-cavitating chest infection. Symptoms include fever, cough and shortness of breath. Peripheral abscesses may also cause pleuritic chest pain 7."
"A primary abscess is one that develops as a result of a primary infection of the lung. These most commonly arise from aspiration, necrotising pneumonia or chronic pneumonia, e.g. in the setting of pulmonary tuberculosis 7 or immunodeficiency 10."
"A secondary abscess is one that develops as a result of another condition. Examples include:"
"Staphylococcus aureus"
"Klebsiella sp: Klebsiella pneumonia"
"Pseudomonas sp"
"Proteus sp"
"Candida albicans: pulmonary candidiasis"
"Legionella micdadei and Legionella pneumophila: Legionella pneumonia"
"Pneumocystis jirovecii (uncommon): Pneumocystis jirovecii pneumonia"
"Despite treatment, abscesses continue to have a high mortality rate (15-20%) 3,6. This is particularly the case with nosocomial infections, which account for the majority of deaths, presumably due to the combined effect of pre-existing illness and the higher prevalence of virulent antibiotic-resistant strains, especially P. aeruginosa (mortality rate of 83%), S. aureus (50%), and Klebsiella pneumoniae (44%) 6."
"Staphylococcus aureus"
"Klebsiella sp: Klebsiella pneumonia"
"Pseudomonas sp"
"Proteus sp"
"Candida albicans: pulmonary candidiasis"
"Legionella micdadei and Legionella pneumophila: Legionella pneumonia"
"Pneumocystis jirovecii (uncommon): Pneumocystis jirovecii pneumonia"
Expected headings
"Complications"
"As a result of the widespread availability of antibiotics, the incidence of lung abscesses has been dramatically reduced. Mortality has similarly been reduced. The elderly, immunocompromised, malnourished, debilitated, and, of course, those who do not have access to antibiotics are particularly susceptible and have the worst prognosis 6. The rate is on the rise, though, particularly due to an increased number of immunocompromised patients (secondary to HIV/AIDS and iatrogenic immunosuppression) 7."
"Lung abscesses are divided, according to their duration, into acute (6 weeks) 7. The presentation is usually non-specific and generally similar to a non-cavitating chest infection. Symptoms include fever, cough and shortness of breath. Peripheral abscesses may also cause pleuritic chest pain 7."
"Lung abscesses are usually managed with prolonged antibiotics and physiotherapy with postural drainage 2. Bronchoscopy may be beneficial in establishing bronchial patency to improve drainage 3. In cases that are refractory to conservative management or those complicated by haemoptysis, empyema or suspected malignancy, surgical resection is the 'traditional' definitive treatment 5. Percutaneous drainage under CT guidance has also been advocated in selected cases (e.g. patients refractory to conventional therapy) 3-9."
"pulmonary cavitating granulomatous disease (e.g. granulomatosis with polyangiitis)"